H.o slashed.vik, Norway

Jostein Holtlund


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jostein Holtlund: Innovator in Immunoassay Technology

Introduction

Jostein Holtlund is a notable inventor based in H.o slashed.vik, Norway. He has made significant contributions to the field of immunoassay technology, particularly through his innovative approaches to analyte detection. With a total of 2 patents to his name, Holtlund's work has the potential to enhance diagnostic methods in various applications.

Latest Patents

Holtlund's latest patents include two groundbreaking inventions. The first is an "Analyte assay using superaggregated complex as labelled reagent," which focuses on improving the accuracy and efficiency of analyte detection. The second patent is an "Immunoassay method and kit using superaggregated complex," which involves methods of assaying samples for the presence or quantity of an analyte. This method utilizes the immobilization of a gold sol, with a mean particle size of less than 20 nm for at least 75% by weight of the particles, formed into a novel superaggregated complex with at least one protein.

Career Highlights

Holtlund is currently associated with Nycomed Pharma AS, a company known for its commitment to advancing pharmaceutical innovations. His work at Nycomed Pharma AS has allowed him to focus on developing cutting-edge technologies that can significantly impact the healthcare industry.

Collaborations

One of Holtlund's notable collaborators is Geir Olav Gogstad. Their partnership has likely contributed to the development of innovative solutions in the field of immunoassays.

Conclusion

Jostein Holtlund's contributions to immunoassay technology through his patents and work at Nycomed Pharma AS highlight his role as an influential inventor in the field. His innovative approaches have the potential to transform diagnostic methods and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…